End-of-day quote
NEO Exchange
06:00:00 2024-07-11 pm EDT
|
5-day change
|
1st Jan Change
|
0.025
CAD
|
0.00%
|
|
0.00%
|
-16.67%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
84.89
|
93.9
|
85.55
|
13.88
|
8.649
|
7.17
|
-
|
Enterprise Value (EV)
1 |
84.89
|
93.9
|
85.55
|
13.88
|
8.649
|
7.17
|
7.17
|
P/E ratio
|
-0.75
x
|
-1
x
|
-1.91
x
|
-0.13
x
|
-0.14
x
|
-0.2
x
|
-0.23
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.56
x
|
0.57
x
|
0.42
x
|
0.08
x
|
0.05
x
|
0.05
x
|
0.04
x
|
EV / Revenue
|
0.56
x
|
0.57
x
|
0.42
x
|
0.08
x
|
0.05
x
|
0.05
x
|
0.04
x
|
EV / EBITDA
|
-6.31
x
|
5.55
x
|
3.8
x
|
4.93
x
|
4.2
x
|
7.31
x
|
2.12
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
306,507
|
323,261
|
372,982
|
376,353
|
382,192
|
390,491
|
-
|
Reference price
2 |
0.2769
|
0.2905
|
0.2294
|
0.0369
|
0.0226
|
0.0184
|
0.0184
|
Announcement Date
|
6/11/20
|
4/15/21
|
3/30/22
|
3/16/23
|
3/14/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
152.9
|
164.7
|
202.7
|
174.2
|
166
|
156.4
|
172.2
|
EBITDA
1 |
-13.45
|
16.92
|
22.5
|
2.815
|
2.06
|
0.9809
|
3.381
|
EBIT
1 |
-104.1
|
-34.6
|
-40.58
|
-90.86
|
-43.15
|
-21.03
|
-19.88
|
Operating Margin
|
-68.07%
|
-21.01%
|
-20.02%
|
-52.16%
|
-26%
|
-13.45%
|
-11.55%
|
Earnings before Tax (EBT)
1 |
-140
|
-57.15
|
-50.15
|
-104.5
|
-67.16
|
-45
|
-44.05
|
Net income
1 |
-130.5
|
-105.8
|
-46.29
|
-107.5
|
-62.38
|
-31.6
|
-28.63
|
Net margin
|
-85.34%
|
-64.23%
|
-22.84%
|
-61.69%
|
-37.59%
|
-20.21%
|
-16.63%
|
EPS
2 |
-0.3700
|
-0.2900
|
-0.1200
|
-0.2900
|
-0.1600
|
-0.0900
|
-0.0800
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/11/20
|
4/15/21
|
3/30/22
|
3/16/23
|
3/14/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
54.06
|
42.35
|
47.06
|
40.49
|
44.29
|
42.26
|
41.6
|
44.56
|
37.54
|
37.5
|
38.25
|
39.61
|
41.02
|
EBITDA
1 |
4.801
|
1.535
|
1.057
|
0.587
|
-0.368
|
-0.079
|
1.539
|
2.241
|
-1.642
|
0.038
|
0.0028
|
0.3086
|
0.6316
|
EBIT
1 |
-36.98
|
-3.378
|
-13.58
|
-6.097
|
-63.71
|
-7.622
|
-13.95
|
-4.724
|
-16.86
|
-5.389
|
-5.425
|
-5.22
|
-4.998
|
Operating Margin
|
-68.42%
|
-7.98%
|
-28.85%
|
-15.06%
|
-143.83%
|
-18.03%
|
-33.54%
|
-10.6%
|
-44.9%
|
-14.37%
|
-14.18%
|
-13.18%
|
-12.18%
|
Earnings before Tax (EBT)
1 |
-35.55
|
-8.975
|
-13.95
|
-9.873
|
-67.67
|
-3.54
|
-31.08
|
-10.64
|
-21.9
|
-11.23
|
-11.47
|
-11.26
|
-11.04
|
Net income
1 |
-30.85
|
-9.064
|
-7.051
|
-15.69
|
-73.08
|
-4.875
|
-26.9
|
-8.663
|
-21.95
|
-9.651
|
-7.454
|
-7.321
|
-7.177
|
Net margin
|
-57.07%
|
-21.4%
|
-14.98%
|
-38.76%
|
-165%
|
-11.53%
|
-64.65%
|
-19.44%
|
-58.48%
|
-25.73%
|
-19.49%
|
-18.48%
|
-17.49%
|
EPS
2 |
-0.0900
|
-0.0200
|
-0.0200
|
-0.0400
|
-0.2000
|
-0.0100
|
-0.0700
|
-0.0200
|
-0.0500
|
-0.0300
|
-0.0200
|
-0.0200
|
-0.0200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/30/22
|
5/16/22
|
8/15/22
|
11/14/22
|
3/16/23
|
5/15/23
|
8/14/23
|
11/13/23
|
3/14/24
|
5/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
31.3
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
20.47%
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/11/20
|
4/15/21
|
3/30/22
|
3/16/23
|
3/14/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -16.67% | 7.17M | | +12.92% | 4.95B | | -32.29% | 3.6B | | -4.28% | 3.03B | | -24.21% | 2.66B | | -8.82% | 2.34B | | +39.33% | 1.85B | | +40.81% | 1.45B | | -14.27% | 1.41B | | +41.90% | 1.38B |
Alternative Medicine
|